Progress in Clinical Study of Eye-gel 2005.03.16

 
(Hong Kong, 16 March 2005) - Lee's Pharmaceutical Holdings Limited (GEM) Stock: 8221; Website: www.leespharm.com) today announced that its clinical trial conducted to generate safety and efficacy data for the Group's in-house product "Protein-free Calf Blood Extract Eye-gel" are making good progress ahead of schedule.

In April 2004, Leespharm announced the approval received from SFDA of the PRC for conducting a clinical study on its product "Protein-free Calf Blood Extract". In January 2005, this randomized, double-blind, multi-center study was initiated by 6 leading hospitals situated in the PRC. In the middle of March, the participated centers have completed more than 50% of the enrollment for this 480 patients study. This study is recruiting rapidly and proceeding satisfactorily. Furthermore, so far this study has indicated that there are no significant adverse issues arising from administration of the product. Researchers at these centers are satisfied with the progress of the study and the patients' responses so far….
 


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD